Corrigendum to“Transferrin-guided intelligent nanovesicles augment the targetability and potency of clinical PLK1 inhibitor to acute myeloid leukemia”[Bioact.Mater.21(March 2023)499-510]  

作　　者：Yifeng Xia Jingnan An Jiaying Li Wenxing Gu Yifan Zhang Songsong Zhao Cenzhu Zhao Yang Xu Bin Li Zhiyuan Zhong Fenghua Meng 

机构地区：[1]Biomedical Polymers Laboratory,College of Chemistry,Chemical Engineering and Materials Science,and State Key Laboratory of Radiation Medicine and Protection,Soochow University,Suzhou,215123,PR China [2]College of Pharmaceutical Sciences,Soochow University,Suzhou,215123,PR China [3]Jiangsu Institute of Hematology,The First Affiliated Hospital of Soochow University,Institute of Blood and Marrow Transplantation of Soochow University,Collaborative Innovation Center of Hematology,Soochow University,Suzhou,215123,PR China [4]Orthopedic Institute,Soochow University,Suzhou,215007,PR China

出　　处：《Bioactive Materials》2024年第1期312-314,共3页生物活性材料（英文）

摘　　要：The authors regret to inform that the blot bands of p-AKT in Fig.3C and the third mouse of 4%TPVol group(D9)in Fig.5B were incorrect.The mistakes were made during the arrangement of the images.The correct form of the two figures are as below.The authors apologize for any inconvenience caused and state that this does not change the discussion and the scientific conclusions of the article.

关 键 词：PLK1 Cor CLINICAL 

分 类 号：G23[文化科学]